Search Results - "de Oña Navarrete, Raquel"

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma by Witzig, Thomas, Sokol, Lubomir, Kim, Won Seog, de la Cruz Vicente, Fátima, Martín García-Sancho, Alejandro, Advani, Ranjana, Roncero Vidal, Jose Maria, de Oña Navarrete, Raquel, Marín-Niebla, Ana, Rodriguez Izquierdo, Antonia, Terol, María José, Domingo-Domenech, Eva, Saunders, Andrew, Bendris, Nawal, Mackey, Julie, Leoni, Mollie, Foss, Francine

“…•The oral farnesyltransferase inhibitor, tipifarnib, as a single agent, produces responses in 40% of patients with heavily pretreated PTCL.•Biomarker…”
Get full text

Bendamustine for Mantle Cell Lymphoma: Retrospective Analysis of the Spanish Experience by García-Noblejas, Ana, Navarro Matilla, Belén, Da Silva Rodriguez, Carolina, De Oña Navarrete, Raquel, Ramirez Sánchez, María José, Nicolás, Concepción, Pérez Fernández, Ricardo, Sanchez Gonzalez, Blanca, Domingo-Domènech, Eva, Sanchez Blanco, Jose Javier, Cannata-Ortiz, Jimena, González-López, Tomás José, Arranz Sáez, Reyes

“…Abstract 4942 Patients with Mantle cell lymphoma (MCL) have an adverse outcome after relapse due to chemorefractory disease with conventional treatments…”
Get full text

Inherited Thrombocytopenias Predisposing to Hematologic Neoplasms. Experience of the Spanish Group for Inherited Platelet Disorders (GEAPC) by Bastida, Jose Maria, Marín-Quílez, Ana, Zamora, Ana, Benito Sanchez, Maria Rocio, Rodriguez Alen, Agustín, Sevivas, Teresa, Gómez-González, Pedro Luis, Díaz-Ajenjo, Lorena, Butta, Nora, Campos, Rosa M., Escribano, Paola, Huertas-Aragoneses, Jorge, Lopez-Duarte, Monica, León, Antonio, Mompel, Angela, De Oña Navarrete, Raquel, Peláez-Pleguezuelos, Irene, Ramos-Ortega, Fernando Jesús, Sebastian, Elena, Serrano, Claudia, Sierra-Aisa, Cristina, Velasco, Pablo, Murillo, Laura, Vidal-Laso, Rosa, Nomdedeu, Meritxell, Esteve Reyner, Jordi, Hernández-Rivas, Jesús María, Rivera Pozo, Jose, Lozano, Maria Luisa

“…Introduction In inherited thrombocytopenic disorders (IT) associated with germline genetic variants in the transcription factors RUNX1 (RUNX1-RT) and ETV6…”
Get full text

Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study by Witzig, Thomas E., Sokol, Lubomir, Jacobsen, Eric D, Kim, Won-Seog, Foss, Francine M., Advani, Ranjana H., Roncero Vidal, Jose Maria, Marin Niebla, Ana, Rodriguez Izquierdo, Antonia, De Ona Navarrete, Raquel, de la Cruz Vicente, Fátima, Caballero, Dolores, Mondejar, Rufino, Piris, Miguel A., Curry, Robert, Scholz, Catherine, Gualberto, Antonio

“…Background Tipifarnib is a potent and selective inhibitor of the enzyme farnesyltransferase (FT). FT catalyzes post-translational attachment of farnesyl groups…”
Get full text